Image

Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

Investigating Early Detection Methods for Pancreatic Cancer in High-Risk Individuals

Recruiting
18 years and older
All
Phase 0
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates pancreatic ductal adenocarcinoma. The purpose of this study is to see if adding blood-based tests and symptom review to standard screening can identify cancer early in high-risk individuals.

The study evaluates the combination of blood tests and symptom reviews with standard screening methods like endoscopic ultrasound and MRI to detect pancreatic cancer early. It assesses the effectiveness of these combined methods.

  • Who can participate: Adults aged 30 and older with certain genetic variants or family history of pancreatic cancer may participate. Participants must not have active pancreatic cancer or any active metastatic cancer and must be able to undergo screening procedures.
  • Study details: Participants will undergo blood tests and symptom reviews. A placebo is not involved in this study.
  • Study timelines: The study will last a minimum of 30 months and up to 20 years.
Print
Study details
    Pancreatic Cancer
    Pancreatic Ductal Adenocarcinoma
    PDAC
    PDAC - Pancreatic Ductal Adenocarcinoma
    Pancreatic Neoplasm

NCT06122896

Dana-Farber Cancer Institute

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.